MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

DGAP-News: MorphoSys AG


/ Key word: Annual Report





MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update






16.03.2022 / 21:01



The... | March 16, 2022

Related Keywords

Germany ,Boston ,Massachusetts ,United States ,Canada ,United Kingdom ,Planegg ,Bayern ,American ,German ,Thomas Biegi ,Julia Neugebauer ,Jean Paul Kress ,Myles Clouston ,Jeanette Bressi ,American Society Of Hematology Annual Meeting ,Xencor Inc ,Linkedin ,Twitter ,Nasdaq ,Morphosys Group Key Figures ,Meeting Of The American Society Nephrology ,Constellation Pharmaceuticals ,National Comprehensive Cancer Network ,Mother Program ,Development Funding Bonds ,Drug Administration ,European Commission ,Us Communications ,Exchange Commission ,Development Rd Expenses ,Health Canada ,Fourth Quarter ,Full Year ,Provides Corporate ,Chief Executive Officer ,Paul Kress ,American Society ,Hematology Annual Meeting ,Monjuvi On March ,Clinical Practice Guidelines ,Program Highlights ,Royalty Pharma ,Royalty Pharma Investments ,Net Profit ,Sys Group Key Figures ,Tax Benefit ,Financial Statements ,Antibody Dependent Cell Mediated Cytotoxicity ,Antibody Dependent Cellular Phagocytosis ,Morphosy Annual Report ,Morphosys Ag Stock Exchange ,News ,Information ,Press Release ,Morphosys ,Key ,Nnual ,G ,Reports ,Fourth ,Quarter ,End ,Bull ,Ear ,021 ,Financial ,Results ,Rovides ,Corporate ,Pdate Mor De0006632003 ,